129 related articles for article (PubMed ID: 7188112)
1. Special therapeutical aspects of cerebrovascular disease.
Lechner H; Ott E
Ric Clin Lab; 1981; 11 Suppl 1():247-51. PubMed ID: 7188112
[TBL] [Abstract][Full Text] [Related]
2. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
Ott E; Lechner H
Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
[TBL] [Abstract][Full Text] [Related]
3. [Combination of phosphatidylcholine and pentoxifylline in the therapy of progressive obstructive stroke].
Tessitore A; Barone A
Acta Neurol Quad (Napoli); 1979; 39():226-8. PubMed ID: 555240
[No Abstract] [Full Text] [Related]
4. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
5. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
Eninia GI; Egere DA; Robule VKh; Maĭore IKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):50-2. PubMed ID: 3953193
[TBL] [Abstract][Full Text] [Related]
6. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
Müller R; Lebrach F
Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
[TBL] [Abstract][Full Text] [Related]
7. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
8. [Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].
Pilla G; Ciaponi A; Migliavacca A; Bonora C
Ric Clin Lab; 1983; 13 Suppl 3():459-64. PubMed ID: 6324325
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of cerebrovascular insufficiency symptoms. Experience from practice].
Ritzmann D
ZFA (Stuttgart); 1976 Dec; 52(34):1788-90. PubMed ID: 1007524
[No Abstract] [Full Text] [Related]
10. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
Müller R; Schröer R
J Med; 1979; 10(5):347-64. PubMed ID: 393790
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
12. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke].
Oláh L; Misz M; Bereczki D; Fekete I; Bordánné JE; Takács EI
Orv Hetil; 1996 Mar; 137(9):455-9. PubMed ID: 8714038
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
14. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
[No Abstract] [Full Text] [Related]
15. Studies on platelet aggregation with pentoxifylline: effect on neoplastic disorders and other new indications.
Ambrus JL; Ambrus CM; Gastpar H
J Med; 1979; 10(5):339-45. PubMed ID: 119023
[No Abstract] [Full Text] [Related]
16. Effect of pentoxifylline on platelet aggregation.
Nenci GG; Gresele P; Agnelli G; Ballatori E
Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
[TBL] [Abstract][Full Text] [Related]
17. [5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Lehrach F; Müller R; Theis H
Med Monatsschr; 1977 Apr; 31(4):159-63. PubMed ID: 853994
[No Abstract] [Full Text] [Related]
18. Symposium on pentoxifylline, Athens, March 22, 1978. Chairman's introduction.
Ambrus JL
J Med; 1979; 10(5):305-6. PubMed ID: 294469
[No Abstract] [Full Text] [Related]
19. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
Hartmann A
Pharmatherapeutica; 1981; 2(8):528-31. PubMed ID: 7255509
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of the cerebrovascular action of pentoxifylline].
Shtok VN; Fedorova NV; Gadanova IV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
